Home
SGMO
SGMO News

Latest Sangamo Therapeutics Inc. (SGMO) News on July 27, 2024

Sangamo Therapeutics Reports on Pfizer’s Announcement of Positive Topline Results From Phase 3 Trial of Hemophilia A Gene Therapy Candidate

Business Wire

3 days ago

Sangamo Therapeutics Reports on Pfizer’s Announcement of Positive Topline Results From Phase 3 Trial of Hemophilia A Gene Therapy Candidate

Sarepta Therapeutics (SRPT) Soars 30.1%: Is Further Upside Left in the Stock?

Zacks

a month ago

Sarepta Therapeutics (SRPT) Soars 30.1%: Is Further Upside Left in the Stock?

We Think Sangamo Therapeutics, Inc.'s (NASDAQ:SGMO) CEO Compensation Package Needs To Be Put Under A Microscope

Simply Wall St.

2 months ago

We Think Sangamo Therapeutics, Inc.'s (NASDAQ:SGMO) CEO Compensation Package Needs To Be Put Under A Microscope

US$3.50 - That's What Analysts Think Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Is Worth After These Results

Simply Wall St.

2 months ago

US$3.50 - That's What Analysts Think Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Is Worth After These Results

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2024 Earnings Call Transcript

Insider Monkey

2 months ago

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2024 Earnings Call Transcript

Sangamo Therapeutics First Quarter 2024 Earnings: US$0.27 loss per share (vs US$0.13 profit in 1Q 2023)

Simply Wall St.

3 months ago

Sangamo Therapeutics First Quarter 2024 Earnings: US$0.27 loss per share (vs US$0.13 profit in 1Q 2023)

GuruFocus.com

3 months ago

Sangamo Therapeutics Reports Q1 2024 Results: A Deep Dive into Financials and Strategic Highlights

Sangamo Therapeutics (SGMO) Reports Q1 Loss, Lags Revenue Estimates

Zacks

3 months ago

Sangamo Therapeutics (SGMO) Reports Q1 Loss, Lags Revenue Estimates

Associated Press Finance

3 months ago

Sangamo: Q1 Earnings Snapshot

Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results

Business Wire

3 months ago

Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results

Sangamo Therapeutics Presents Next-Generation Modular Integrase Technology Engineered to Enable Large-Scale Genome Editing

Business Wire

3 months ago

Sangamo Therapeutics Presents Next-Generation Modular Integrase Technology Engineered to Enable Large-Scale Genome Editing

Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates

Zacks

3 months ago

Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates

Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast

Business Wire

3 months ago

Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast

Sangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Business Wire

3 months ago

Sangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

What You Need To Know About The Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Analyst Downgrade Today

Simply Wall St.

4 months ago

What You Need To Know About The Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Analyst Downgrade Today

Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering

Business Wire

4 months ago

Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering

Sangamo Therapeutics Full Year 2023 Earnings: Misses Expectations

Simply Wall St.

4 months ago

Sangamo Therapeutics Full Year 2023 Earnings: Misses Expectations

Thomson Reuters StreetEvents

4 months ago

Q4 2023 Sangamo Therapeutics Inc Earnings Call

Associated Press Finance

4 months ago

Sangamo: Q4 Earnings Snapshot

Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

Business Wire

4 months ago

Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

Sangamo Therapeutics Announces Data From Novel Proprietary Neurotropic AAV Capsid Demonstrating Industry-leading Blood-brain Barrier Penetration and Brain Transduction in NHPs

Business Wire

4 months ago

Sangamo Therapeutics Announces Data From Novel Proprietary Neurotropic AAV Capsid Demonstrating Industry-leading Blood-brain Barrier Penetration and Brain Transduction in NHPs

Sangamo Therapeutics Announces Fourth Quarter and Full Year 2023 Conference Call and Webcast

Business Wire

4 months ago

Sangamo Therapeutics Announces Fourth Quarter and Full Year 2023 Conference Call and Webcast

Sangamo Therapeutics Announces U.S. FDA Alignment on Abbreviated Pathway to Potential Approval and EMA Prime Eligibility for ST-920 in Fabry Disease

Business Wire

5 months ago

Sangamo Therapeutics Announces U.S. FDA Alignment on Abbreviated Pathway to Potential Approval and EMA Prime Eligibility for ST-920 in Fabry Disease

With 55% ownership of the shares, Sangamo Therapeutics, Inc. (NASDAQ:SGMO) is heavily dominated by institutional owners

Simply Wall St.

5 months ago

With 55% ownership of the shares, Sangamo Therapeutics, Inc. (NASDAQ:SGMO) is heavily dominated by institutional owners

Business Wire

6 months ago

Sangamo Therapeutics Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit and Differentiated Safety Profile

Seanergy Maritime Achieves Key Partnership with European Union Funding and Major Industry Stakeholders Under SAFeCRAFT to Revolutionize Maritime Propulsion for Existing Vessels

GlobeNewswire

6 months ago

Seanergy Maritime Achieves Key Partnership with European Union Funding and Major Industry Stakeholders Under SAFeCRAFT to Revolutionize Maritime Propulsion for Existing Vessels

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

6 months ago

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum (MIRM) Banks on Livmarli Sales Despite Recent Setback

Zacks

6 months ago

Mirum (MIRM) Banks on Livmarli Sales Despite Recent Setback

Syros (SYRS) Stock Surges 200% in 3 Months: Here's Why

Zacks

6 months ago

Syros (SYRS) Stock Surges 200% in 3 Months: Here's Why

Vor Bio (VOR) Up on Positive Update From AML Cell Therapy Study

Zacks

6 months ago

Vor Bio (VOR) Up on Positive Update From AML Cell Therapy Study

Molecular Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

7 months ago

Molecular Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference

Eltek (NASDAQ:ELTK) Is Very Good At Capital Allocation

Simply Wall St.

7 months ago

Eltek (NASDAQ:ELTK) Is Very Good At Capital Allocation

Spruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAH

Business Wire

7 months ago

Spruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAH

Individual investors in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) are its biggest bettors, and their bets paid off as stock gained 20% last week

Simply Wall St.

7 months ago

Individual investors in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) are its biggest bettors, and their bets paid off as stock gained 20% last week

Crunch Fitness, Appian, Pinstripes CEOs and more: C-Suite Insights

Yahoo Finance Video

7 months ago

Crunch Fitness, Appian, Pinstripes CEOs and more: C-Suite Insights

Spruce Biosciences Provides Clinical Program Updates and Outlook for 2024

Business Wire

7 months ago

Spruce Biosciences Provides Clinical Program Updates and Outlook for 2024

Pinstripes looking to expand internationally, CEO explains

Yahoo Finance Video

7 months ago

Pinstripes looking to expand internationally, CEO explains

Does Brainsway Ltd. Sponsored ADR (BWAY) Have the Potential to Rally 48.15% as Wall Street Analysts Expect?

Zacks

7 months ago

Does Brainsway Ltd. Sponsored ADR (BWAY) Have the Potential to Rally 48.15% as Wall Street Analysts Expect?

Business Wire

7 months ago

Bragg Gaming Supplies Online Casino Game Aggregation for Superbet in Brazil

How Much Upside is Left in 908 Devices Inc. (MASS)? Wall Street Analysts Think 100.39%

Zacks

7 months ago

How Much Upside is Left in 908 Devices Inc. (MASS)? Wall Street Analysts Think 100.39%

7 Dividend Stocks I Wouldn’t Touch With a 10-Foot Pole

InvestorPlace

7 months ago

7 Dividend Stocks I Wouldn’t Touch With a 10-Foot Pole

3 Growthy Gaming Stocks Worth Playing in 2024

InvestorPlace

7 months ago

3 Growthy Gaming Stocks Worth Playing in 2024

Frequency Electronics, Inc.'s (NASDAQ:FEIM) Stock Is Going Strong: Have Financials A Role To Play?

Simply Wall St.

7 months ago

Frequency Electronics, Inc.'s (NASDAQ:FEIM) Stock Is Going Strong: Have Financials A Role To Play?

What Makes Corvus (CRVS) a New Buy Stock

Zacks

8 months ago

What Makes Corvus (CRVS) a New Buy Stock

Business Wire

8 months ago

dMY Squared Technology Group, Inc. Announces Postponement of Special Meeting to January 2, 2024 and Extension of Redemption Deadline to December 28, 2023

Syntec Optics Holdings, Inc.'s (NASDAQ:OPTX) top owners are individual investors with 55% stake, while 45% is held by insiders

Simply Wall St.

8 months ago

Syntec Optics Holdings, Inc.'s (NASDAQ:OPTX) top owners are individual investors with 55% stake, while 45% is held by insiders

U.S. Century Bank Names William Turner New Executive Vice President and Chief Credit Officer

GlobeNewswire

8 months ago

U.S. Century Bank Names William Turner New Executive Vice President and Chief Credit Officer

Analysts Expect Breakeven For Bragg Gaming Group Inc. (TSE:BRAG) Before Long

Simply Wall St.

8 months ago

Analysts Expect Breakeven For Bragg Gaming Group Inc. (TSE:BRAG) Before Long

Syntec Optics to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference (Nasdaq: OPTX)

GlobeNewswire

8 months ago

Syntec Optics to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference (Nasdaq: OPTX)

Shell's (SHEL) Prelude LNG Facility to Restart in December

Zacks

8 months ago

Shell's (SHEL) Prelude LNG Facility to Restart in December

Returns Are Gaining Momentum At Big 5 Sporting Goods (NASDAQ:BGFV)

Simply Wall St.

8 months ago

Returns Are Gaining Momentum At Big 5 Sporting Goods (NASDAQ:BGFV)

VIZSLA SILVER REPORTS ADDITIONAL HIGH-GRADE INTERCEPTS ON THE COPALA AND COPALA 2 STRUCTURES

CNW Group

8 months ago

VIZSLA SILVER REPORTS ADDITIONAL HIGH-GRADE INTERCEPTS ON THE COPALA AND COPALA 2 STRUCTURES

Companies Like Sangamo Therapeutics (NASDAQ:SGMO) Could Be Quite Risky

Simply Wall St.

8 months ago

Companies Like Sangamo Therapeutics (NASDAQ:SGMO) Could Be Quite Risky

Noventiq Launches Weaver Peer – the Indispensable AI Team Member for Business Growth

Business Wire

8 months ago

Noventiq Launches Weaver Peer – the Indispensable AI Team Member for Business Growth

Need To Know: The Consensus Just Cut Its Seer, Inc. (NASDAQ:SEER) Estimates For 2024

Simply Wall St.

8 months ago

Need To Know: The Consensus Just Cut Its Seer, Inc. (NASDAQ:SEER) Estimates For 2024

Summit Midstream Partners, LP Announces Opportunistic Refinancing of its 2025 Unsecured Notes and Amendment to ABL Facility

PR Newswire

8 months ago

Summit Midstream Partners, LP Announces Opportunistic Refinancing of its 2025 Unsecured Notes and Amendment to ABL Facility

Farallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks

Insider Monkey

8 months ago

Farallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks

Omeros Corporation (NASDAQ:OMER) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

Omeros Corporation (NASDAQ:OMER) Q3 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

9 months ago

Q3 2023 Omeros Corp Earnings Call

Inogen (INGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

9 months ago

Inogen (INGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Associated Press Finance

9 months ago

Omeros: Q3 Earnings Snapshot

Omeros Corporation Reports Third Quarter 2023 Financial Results

Business Wire

9 months ago

Omeros Corporation Reports Third Quarter 2023 Financial Results

Profound Medical to Participate in the Stifel 2023 Healthcare Conference

GlobeNewswire

9 months ago

Profound Medical to Participate in the Stifel 2023 Healthcare Conference

BlackSky Makes 2023 Deloitte Technology Fast 500™ List of America's Fastest-Growing Companies

Business Wire

9 months ago

BlackSky Makes 2023 Deloitte Technology Fast 500™ List of America's Fastest-Growing Companies

Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update

GlobeNewswire

9 months ago

Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update

Perma-Fix Environmental Services, Inc. (NASDAQ:PESI) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Perma-Fix Environmental Services, Inc. (NASDAQ:PESI) Q3 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

9 months ago

Q3 2023 Perma-Fix Environmental Services Inc Earnings Call

Upland Software (UPLD) Reports Q3 Earnings: What Key Metrics Have to Say

Zacks

9 months ago

Upland Software (UPLD) Reports Q3 Earnings: What Key Metrics Have to Say

Perma-Fix Reports 18% Year-Over-Year Increase in Revenue to $21.9 Million for the Third Quarter of 2023

GlobeNewswire

9 months ago

Perma-Fix Reports 18% Year-Over-Year Increase in Revenue to $21.9 Million for the Third Quarter of 2023

Share on Social Networks: